Sumitomo Mitsui Asset Management Company LTD trimmed its stake in shares of Stericycle Inc (NASDAQ:SRCL) by 30.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,176 shares of the business services provider’s stock after selling 12,051 shares during the period. Sumitomo Mitsui Asset Management Company LTD’s holdings in Stericycle were worth $1,594,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently bought and sold shares of SRCL. Whittier Trust Co. raised its position in shares of Stericycle by 362.6% in the second quarter. Whittier Trust Co. now owns 1,087 shares of the business services provider’s stock valued at $129,000 after buying an additional 852 shares during the last quarter. Dupont Capital Management Corp raised its position in shares of Stericycle by 102.2% in the second quarter. Dupont Capital Management Corp now owns 2,089 shares of the business services provider’s stock valued at $136,000 after buying an additional 1,056 shares during the last quarter. NumerixS Investment Technologies Inc raised its position in shares of Stericycle by 285.0% in the second quarter. NumerixS Investment Technologies Inc now owns 2,695 shares of the business services provider’s stock valued at $174,000 after buying an additional 1,995 shares during the last quarter. Intact Investment Management Inc. acquired a new stake in shares of Stericycle in the second quarter valued at about $202,000. Finally, Caisse DE Depot ET Placement DU Quebec acquired a new stake in shares of Stericycle in the second quarter valued at about $210,000. 94.59% of the stock is currently owned by institutional investors and hedge funds.
In related news, CFO Daniel Ginnetti sold 5,000 shares of the firm’s stock in a transaction dated Wednesday, August 1st. The shares were sold at an average price of $70.00, for a total transaction of $350,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Over the last 90 days, insiders have sold 10,060 shares of company stock valued at $707,912. 3.50% of the stock is owned by company insiders.
A number of equities research analysts have recently commented on the stock. Northcoast Research reiterated a “neutral” rating on shares of Stericycle in a research report on Friday, October 12th. Zacks Investment Research cut shares of Stericycle from a “hold” rating to a “sell” rating in a research report on Tuesday, October 9th. Barrington Research set a $72.00 target price on shares of Stericycle and gave the company a “buy” rating in a research report on Friday, October 5th. BidaskClub cut shares of Stericycle from a “hold” rating to a “sell” rating in a research report on Friday, October 5th. Finally, BMO Capital Markets reduced their target price on shares of Stericycle from $71.00 to $63.00 and set a “market perform” rating for the company in a research report on Monday, August 6th. Four research analysts have rated the stock with a sell rating, four have assigned a hold rating and three have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $71.29.
Stericycle stock opened at $53.05 on Friday. Stericycle Inc has a 12-month low of $51.45 and a 12-month high of $76.73. The stock has a market cap of $4.56 billion, a P/E ratio of 12.22, a PEG ratio of 1.31 and a beta of 0.35. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 0.87.
Stericycle (NASDAQ:SRCL) last released its quarterly earnings data on Thursday, August 2nd. The business services provider reported $1.17 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.13 by $0.04. Stericycle had a net margin of 5.03% and a return on equity of 14.04%. The firm had revenue of $883.30 million during the quarter, compared to analysts’ expectations of $896.62 million. During the same period last year, the business earned $1.15 earnings per share. Stericycle’s revenue was down 3.7% compared to the same quarter last year. As a group, equities research analysts predict that Stericycle Inc will post 4.43 earnings per share for the current year.
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.
Read More: What factors cause inflation to rise?
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.